GROUPAMA ASSET MANAGMENT

Position in MRK — Merck & Co., Inc.

CIK 1055969 PARIS, I0

Position in MRK

as of Mar 31, 2026 · filed May 22, 2026 Compact

Position Value

$105,249,299

+$10,432,565 QoQ

Shares Held

874,963

-2.9% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

1.54%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 86.05198162665164.ToString("F0")% Shared 0.ToString("F0")% None 13.948018373348358.ToString("F0")%

Healthcare · as of Mar 31, 2026

GROUPAMA ASSET MANAGMENT holds $418,001,230 across 10 Drug Manufacturers - General names. MRK ranks #2 (25.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	863,629	$170,324,911
2	MRK	Merck & Co., Inc. This page	874,963	$105,249,299
3	LLY	ELI LILLY & Co	95,376	$87,723,983
4	ABBV	AbbVie Inc.	156,150	$33,961,063
5	JNJ	Johnson & Johnson	22,693	$5,547,076
6	GILD	Gilead Sciences, Inc.	37,990	$5,294,666
7	AMGN	Amgen Inc	14,960	$5,263,676
8	PFE	Pfizer Inc	63,889	$1,794,003

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$105,249,299	874,963	-2.9%	Shares	Sole	2026-05-22
2025-12-31	$94,816,734	900,786	+8.2%	Shares	Sole	2026-02-27
2025-09-30	$69,880,537	832,605	+6.3%	Shares	Sole	2025-12-01
2025-06-30	$61,987,346	783,064	-9.2%	Shares	Sole	2025-08-13
2025-03-31	$77,405,343	862,359	+9.2%	Shares	Sole	2025-05-14
2024-12-31	$78,568,109	789,788	-49.2%	Shares	Other	2025-02-12
2024-09-30	$176,528,678	1,554,497	+10.3%	Shares	Other	2024-11-15
2024-06-30	$174,500,556	1,409,536	+102.5%	Shares	Sole	2024-08-14
2024-03-31	$91,842,740	696,042	-53.8%	Shares	Sole	2024-05-14
2023-12-31	$164,117,508	1,505,389	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.